Public Health England , 2018. Malaria imported into the United Kingdom: 2018. Implications for those advising travellers. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/812824/Malaria_imported_into_the_United_Kingdom_2018.pdf. Accessed August 16, 2020.
Lalloo DG , Shingadia D , Bell DJ , Beeching NJ , Whitty CJM , Chiodini PL , 2016. UK malaria treatment guidelines 2016. J Infect 72: 635–649.
Seedat F , Hargreaves S , Nellums LB , Ouyang J , Brown M , Friedland JS , 2018. How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review. Lancet Infect Dis 18: e259–e271.
European Centre for Disease Prevention and Control , 2018. Public Health Guidance on Screening and Vaccination for Infectious Diseases in Newly Arrived Migrants within the EU/EEA. Available at: https://www.ecdc.europa.eu/en/publications-data/public-health-guidance-screening-and-vaccination-infectious-diseases-newly. Accessed August 9, 2020.
Public Health England , 2019. Assessing New Patients from Overseas: Migrant Health guide. Available at: https://www.gov.uk/guidance/assessing-new-patients-from-overseas-migrant-health-guide. Accessed March 8, 2021.
Public Health England, 2019 Imported Malaria in South London: 2019 Annual Report (Data from 2018). Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/838594/Annual_South_London_malaria_report_2019.pdf. Accessed March 8, 2021.
Ghosh K , Javeri KN , Mohanty D , Parmar BD , Surati RR , Joshi SH , 2001. False-positive serological tests in acute malaria. Br J Biomed Sci 58: 20–23.
Public Health England , 2018. Annual Epidemiological Spotlight on HIV in London: 2017 Data. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/767460/LondonHIVSpotlight2017.pdf. Accessed August 9, 2020.
Evans H , Balasegaram S , Douthwaite S , Hunter L , Kulasegaram R , Wong T , Querol-Rubiera A , Nebbia G , 2018. An innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a London Emergency Department. PLoS One 13: e0198520.
Takaoka K , Gourtsoyannis Y , Hart JD , Armstrong M , Daniel A , Mewse E , Phillips D , Bailey RL , 2016. Incidence rate and risk factors for giardiasis and strongyloidiasis in returning UK travellers. J Travel Med 23. doi: .
Agbata EN et al., 2018. Effectiveness of screening and treatment approaches for schistosomiasis and strongyloidiasis in newly-arrived migrants from endemic countries in the EU/EEA: a systematic review. Int J Environ Res Public Health 16: 11.
Coltart C , Chew A , Storrar N , Armstrong M , Suff N , Morris L , Chiodini P , Whitty C , 2015. Schistosomiasis presenting in travellers: a 15 year observational study at the Hospital for Tropical Diseases, London. Trans R Soc Trop Med Hyg 109: 214–220.
Pareek M et al., 2019. Community-based testing of migrants for infectious diseases (COMBAT-ID): impact, acceptability and cost-effectiveness of identifying infectious diseases among migrants in primary care: protocol for an interrupted time-series, qualitative and health economic analysis. BMJ Open 9: e029188.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 459 | 201 | 11 |
Full Text Views | 76 | 49 | 2 |
PDF Downloads | 73 | 41 | 1 |
The United Kingdom’s cases of malaria infection are primarily acquired in sub-Saharan Africa, with the majority of infections presenting in London. When patients go to a hospital with malaria, there is a screening opportunity for other geographically associated chronic infections. We identified patients who were diagnosed with malaria after presenting to our emergency department in London over a 2-year period, to assess whether there may be clinical benefit in screening for chronic viral (hepatitis B, hepatitis C, HIV) or parasitic (schistosomiasis, strongyloidiasis) infection in this cohort. Over this period, 131 patients were diagnosed with malaria. Crude seropositivity rates for HIV, hepatitis B, and strongyloidiasis were higher than expected compared with local population estimates, 7 and 28 times higher for HIV and hepatitis B, respectively. Those patients with previously unidentified cases were offered appropriate treatment. These findings support the potential clinical and public health benefits of screening for other infectious diseases in the context of a malaria diagnosis.
Authors’ addresses: Alison Gowland, Emma McGuire, and Anna L. Goodman, Guy’s and St. Thomas’ NHS Foundation Trust, London, United Kingdom, E-mails: alison.gowland@nhs.net, emcguire1@nhs.net, and anna.goodman@gstt.nhs.uk.